We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Nanoplastics in infusion system remains underexplored: Evidence from detected nanoplastics in hospital-sourced infusion products
Summary
Researchers analyzed hospital-sourced infusion products from three brands for nanoplastic contamination using surface-enhanced Raman spectroscopy combined with dark-field microscopy. The study detected a variety of nanoplastic particles in infusion products, suggesting that intravenous therapy may represent an underexplored pathway for direct nanoplastic exposure in clinical settings.
Recent studies have highlighted the potential pathway of microplastic exposure through infusion therapy. However, the release of nanoplastics during this process remains poorly understood. Existing research on nanoplastics in infusion products predominantly relies on non-specific detection methods, which can significantly compromise the accurate judgment of nanoplastic types and concentrations. In this study, three brands of hospital-sourced infusion products were analyzed for nanoplastic release using surface-enhanced Raman spectroscopy (SERS) combined with dark-field microscopy. A wide variety of nanoplastics, including polypropylene (PP), polyvinyl chloride (PVC), polystyrene (PS), polymethyl methacrylate (PMMA), polyethylene terephthalate (PET), polyamide (PA), and polyethylene (PE), was detected. Among them, PP nanoplastics (PP-NPs) and PVC nanoplastics (PVC-NPs) were found at high concentrations, ranging from 7436.8 to 16439.3 particles per bag and 3914.1-7045.4 particles per tube, respectively. In addition to these dominant species, the combined concentration of the remaining five nanoplastics (PS, PMMA, PET, PA, and PE) ranged from 2818 to 24189.3 particles per bag/tube. This level of compositional diversity has not been previously reported, raising urgent concerns regarding nanoplastic exposure through infusion therapy and underscoring the need for further investigation.
Sign in to start a discussion.
More Papers Like This
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Unraveling micro/nanoplastics and phthalates in infusion solutions: A novel integrated approach for quantification and cardiovascular cytotoxicity evaluation
Researchers developed a new method to detect and measure micro- and nanoplastics in medical infusion solutions (IV bags) and found significant contamination in commonly used glucose and saline fluids. Nanoplastics dominated the contamination, with polyethylene, polypropylene, and polystyrene detected alongside phthalate chemicals that showed a strong correlation with plastic particle levels. The study suggests that IV therapy may be an overlooked route of direct plastic particle exposure into the bloodstream, and that combined exposure to nanoplastics and phthalates can have synergistic toxic effects on cardiovascular cells.
Microplastic particles and infusion therapy — Evidence, implications, and unanswered questions
This review highlights infusion therapy via medical devices and pharmaceutical containers as a significant but often overlooked route of microplastic exposure in humans. The study emphasizes that despite strict regulations, advances in clinical research have not been fully integrated into current industry testing standards, and calls for a standardized, multi-method approach to microplastic detection and risk assessment in medical settings.
Is intravenous infusion an unrecognized route for internal microplastic human exposure? A general assessment
This study discovered that microplastics are present in intravenous (IV) infusion products used in hospitals, identifying a previously unrecognized route of microplastic exposure that bypasses the body's natural barriers. Standard IV filters removed some but not all of the plastic particles. This finding is important because IV-delivered microplastics go directly into the bloodstream, potentially posing a greater risk than microplastics that are eaten or inhaled.
Rapid detection of microplastics/nanoplastics directly exposed to blood during intravenous injections via mie scattering spectra
Researchers discovered that medical IV equipment releases microplastics and nanoplastics directly into patients' bloodstreams, with infusion tubing being the primary source at concentrations of about 8.4 micrograms per liter. The particles were mainly PVC fibers from the tubing itself. The study recommends reducing unnecessary IV treatments and discarding the first 12 milliliters of saline from tubing to reduce this previously unrecognized source of direct microplastic exposure to human blood.